• Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

BioPharma News

Biopharmaceutical industry analysis. Credible, reliable, equitable.

Subscribe
  • Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe

EMA

Posted inInfections, Research

Monkeypox 2022. Full Review

by Mark Gubar, Tanya von Reuss, Julia Mardi, Alex Avisoni and Timur Burkhanayev June 1, 2022April 11, 2024

Monkeypox as a new threat to humanity.

Posted inMetabolism, New Drugs, Regulatory

Kerendia: New Drug for Diabetic Kidney Disease

by Mark Gubar February 16, 2022September 8, 2022

Finerenone for the treatment of diabetic nephropathy, a chronic kidney disease associated with type 2 diabetes mellitus.

Posted inAutoimmune Diseases, New Drugs, Rare/Orphan Diseases, Regulatory

Tavneos: New Drug for ANCA-Associated Vasculitis

by Tanya von Reuss February 5, 2022September 8, 2022

Avacopan is better than prednisone in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis.

Posted inCardiology, Metabolism, New Drugs, Rare/Orphan Diseases, Regulatory

Leqvio: Newest Drug Against ‘Very Bad’ Cholesterol

by Mark Gubar December 23, 2021April 5, 2024

Two injections of inclisiran a year and you can forget about high cholesterol. Novartis doesn’t lie.

Posted inInfections, New Drugs, Regulatory

Fetroja/Fetcroja: New Cephalosporin That Bypasses All Antibiotic Resistance

by Nik Resovski December 11, 2021September 8, 2022

The antibiotic Fetroja/Fetcroja penetrates bacteria like a Trojan horse.

Posted inNew Drugs, Rare/Orphan Diseases, Regulatory

Trikafta/Kaftrio: World’s First Triple Therapy for Cystic Fibrosis

by Mark Gubar and Julia Mardi December 9, 2021September 8, 2022

The combination drug will help almost all cystic fibrosis patients.

dwarf family
Posted inNew Drugs, Rare/Orphan Diseases, Regulatory

Voxzogo: First Drug to Treat Dwarfism

by Tanya von Reuss and Julia Mardi December 6, 2021September 8, 2022

Vosoritide by BioMarin Pharmaceutical may cure achondroplasia.

Posts pagination

Newer posts 1 2 3 4 Older posts
BioPharma News Logo
Biopharmaceutical industry analysis.
© 2025 BioPharma News Powered by Newspack Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

Awareness and enlightenment are strengths.

BioPharma News is an amazing and trustworthy non-profit data analysis service that provides honest and objective reporting on the Pharma & Biotech industry. We would like to invite you to sign up for our weekly Newsletter to stay informed and uptodate.

Please check your inbox or spam folder for an email from [email protected] to confirm your subscription.

×